Details
Stereochemistry | ACHIRAL |
Molecular Formula | C48H38F8N8O8S4 |
Molecular Weight | 1135.111 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNS(=O)(=O)C1=CC=C(F)C(=C1F)C2=C3CCC(=N3)C(=C4NC(C=C4)=C(C5=NC(CC5)=C(C6=CC=C2N6)C7=C(F)C(=CC=C7F)S(=O)(=O)NC)C8=C(F)C(=CC=C8F)S(=O)(=O)NC)C9=C(F)C(=CC=C9F)S(=O)(=O)NC
InChI
InChIKey=CKRVBMUJCFKRND-ZXWMLXKTSA-N
InChI=1S/C48H38F8N8O8S4/c1-57-73(65,66)33-17-5-21(49)37(45(33)53)41-25-9-11-27(61-25)42(38-22(50)6-18-34(46(38)54)74(67,68)58-2)29-13-15-31(63-29)44(40-24(52)8-20-36(48(40)56)76(71,72)60-4)32-16-14-30(64-32)43(28-12-10-26(41)62-28)39-23(51)7-19-35(47(39)55)75(69,70)59-3/h5-9,11,14,16-20,57-61,64H,10,12-13,15H2,1-4H3/b41-25+,41-26+,42-27+,42-29+,43-28+,43-30+,44-31+,44-32+
Molecular Formula | C48H38F8N8O8S4 |
Molecular Weight | 1135.111 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:25:06 UTC 2023
by
admin
on
Sat Dec 16 11:25:06 UTC 2023
|
Record UNII |
ZP3QP1H44W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/15/1470
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
||
|
FDA ORPHAN DRUG |
556616
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ZP3QP1H44W
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
100000183241
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
10170
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
86287614
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
1224104-08-8
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
C114382
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY | |||
|
SUB197619
Created by
admin on Sat Dec 16 11:25:06 UTC 2023 , Edited by admin on Sat Dec 16 11:25:06 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: Bluepharma, Universidade de Coimbra; Developer: Luzitin; Class: Antineoplastic, Macrocyclic compound, Porphyrin; Mechanism of Action: Photosensitiser; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes; Available For Licensing: Yes; Highest Development Phase: Phase II for Head and neck cancer; Most Recent Events: 15 Mar 2016 Phase-II clinical trials in Head and neck cancer in Portugal (IV), 20 Feb 2014 Phase-I/II clinical trials in Head and neck cancer in Portugal (IV), 08 Dec 2012 Luzitin licensed patents by Bluepharma and Universidade de Coimbra
|